Amundi’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
18,349
-103,250
-85% -$7.04M ﹤0.01% 1266
2026
Q1
$7.86M Buy
121,599
+101,451
+504% +$7.15M ﹤0.01% 903
2025
Q4
$1.36M Buy
20,148
+11,170
+124% +$751K ﹤0.01% 1217
2025
Q3
$601K Sell
8,978
-460
-5% -$30.6K ﹤0.01% 1278
2025
Q2
$508K Buy
9,438
+3,339
+55% +$190K ﹤0.01% 1370
2025
Q1
$378K Sell
6,099
-266
-4% -$15.5K ﹤0.01% 1554
2024
Q4
$342K Buy
+6,365
New +$326K ﹤0.01% 1637
2024
Q3
Sell
-120,427
Closed -$6.26M 1985
2024
Q2
$6.26M Sell
120,427
-29,462
-20% -$1.29M ﹤0.01% 922
2024
Q1
$5.67M Buy
149,889
+91,781
+158% +$3.44M ﹤0.01% 945
2023
Q4
$2.03M Buy
58,108
+43,508
+298% +$1.64M ﹤0.01% 1197
2023
Q3
$534K Sell
14,600
-1,049
-7% -$43K ﹤0.01% 1403
2023
Q2
$577K Sell
15,649
-237
-1% -$8.09K ﹤0.01% 1365
2023
Q1
$595K Sell
15,886
-1
-0% -$47 ﹤0.01% 1343
2022
Q4
$803K Buy
15,887
+1,407
+10% +$72K ﹤0.01% 1331
2022
Q3
$603K Buy
14,480
+8,147
+129% +$360K ﹤0.01% 1317
2022
Q2
$299K Sell
6,333
-1,004
-14% -$43.4K ﹤0.01% 1323
2022
Q1
$307K Sell
7,337
-1,575
-18% -$56.1K ﹤0.01% 1340
2021
Q4
$316K Hold
8,912
﹤0.01% 1444
2021
Q3
$363K Buy
8,912
+1,526
+21% +$63.8K ﹤0.01% 1386
2021
Q2
$335K Buy
+7,386
New +$327K ﹤0.01% 1309

Other funds holding HALO

Amundi's HALO Position: Q2 2026 in Review

Amundi reduced its Halozyme (HALO) stake by 85% in Q2 2026, selling an estimated $7.04M and leaving 18,349 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Amundi first reported a position in HALO in Q2 2021 and has held it in 20 quarters since. The position peaked at $7.86M in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Amundi held 18,349 shares of Halozyme worth $1.44M as of Q2 2026.
  • Amundi sold 103,250 Halozyme shares in Q2 2026, an estimated $7.04M.
  • Halozyme made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1266 holding.
  • Amundi first reported a position in Halozyme in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Halozyme position peaked at $7.86M in Q1 2026.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.